Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|March 9, 2023
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancerLoek A W de Jong, Marie Lambert, Nielka P van Erp, et al.Cancer Chemotherapy and Pharmacology|April 15, 2022
Is age just a number? A population pharmacokinetic study of gemcitabineRené J Boosman, Marie-Rose B S Crombag, Nielka P van Erp, et al.BMC Cancer|August 9, 2014
Effect of gastrointestinal resection on sunitinib exposure in patients with GISTDjoeke de Wit, Nielka P van Erp, Reza Khosravan, et al.Journal of Clinical Pharmacology|June 3, 2015
Dried blood spot analysis for therapeutic drug monitoring of pazopanibDjoeke de Wit, Jan den Hartigh, Hans Gelderblom, et al.International Journal of Cancer|October 11, 2015
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithmAnnelieke E C A B Willemsen, Jan C Grutters, Winald R Gerritsen, et al.British Journal of Clinical Pharmacology|July 11, 2019
The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumoursFloor J E Lubberman, Winette T A van der Graaf, Lei Xu, et al.British Journal of Clinical Pharmacology|December 2, 2025
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistatAnnemieke M Peters van Ton, Nielka P van Erp, Annenienke C van de Ven, et al.Cancer Chemotherapy and Pharmacology|September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokineticsFloor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.British Journal of Clinical Pharmacology|September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gapGuillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.Clinical Pharmacology and Therapeutics|June 1, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma PatientsAmy Rieborn, Eline L Giraud, Teun van Gelder, et al.Pageof 11